267 related articles for article (PubMed ID: 11858799)
41. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
[TBL] [Abstract][Full Text] [Related]
42. A2 noradrenergic neurons regulate forced swim test immobility.
Nam H; Kerman IA
Physiol Behav; 2016 Oct; 165():339-49. PubMed ID: 27553574
[TBL] [Abstract][Full Text] [Related]
43. The effect of Schisandra chinensis extracts on depression by noradrenergic, dopaminergic, GABAergic and glutamatergic systems in the forced swim test in mice.
Yan T; Xu M; Wu B; Liao Z; Liu Z; Zhao X; Bi K; Jia Y
Food Funct; 2016 Jun; 7(6):2811-9. PubMed ID: 27225351
[TBL] [Abstract][Full Text] [Related]
44. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
Cenci MA; Kalén P; Duan WM; Björklund A
Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
[TBL] [Abstract][Full Text] [Related]
45. Are ascending noradrenergic and serotonergic pathways necessary for effects of electroconvulsive treatment? Clonidine hypothermia and forced swim study.
Danysz W; Kostowski W; Hauptmann M; Bidzinski A
Pol J Pharmacol Pharm; 1989; 41(1):15-22. PubMed ID: 2511561
[TBL] [Abstract][Full Text] [Related]
46. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
[TBL] [Abstract][Full Text] [Related]
47. A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice.
Poleszak E; Wlaź P; Szewczyk B; Wlaź A; Kasperek R; Wróbel A; Nowak G
J Neural Transm (Vienna); 2011 Nov; 118(11):1535-46. PubMed ID: 21461743
[TBL] [Abstract][Full Text] [Related]
48. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.
Detke MJ; Rickels M; Lucki I
Psychopharmacology (Berl); 1995 Sep; 121(1):66-72. PubMed ID: 8539342
[TBL] [Abstract][Full Text] [Related]
49. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
Radwanska K; Nikolaev E; Kaczmarek L
Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
[TBL] [Abstract][Full Text] [Related]
50. On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression.
Danysz W; Kostowski W; Kozak W; Hauptmann M
Pol J Pharmacol Pharm; 1986; 38(3):285-98. PubMed ID: 3022258
[TBL] [Abstract][Full Text] [Related]
51. Central noradrenergic activity affects analgesic effect of Neuropeptide S.
Jinushi K; Kushikata T; Kudo T; Calo G; Guerrini R; Hirota K
J Anesth; 2018 Feb; 32(1):48-53. PubMed ID: 29128909
[TBL] [Abstract][Full Text] [Related]
52. The need for new and better antidepressants: reboxetine a new option.
Dencker SJ
Acta Psychiatr Scand Suppl; 2000; 402():6-11. PubMed ID: 10901153
[TBL] [Abstract][Full Text] [Related]
53. The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice.
Poleszak E; Wośko S; Serefko A; Wlaź A; Kasperek R; Dudka J; Wróbel A; Nowak G; Wlaź P
Pharmacol Rep; 2014 Dec; 66(6):1031-6. PubMed ID: 25443731
[TBL] [Abstract][Full Text] [Related]
54. A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus.
Giorgi FS; Ferrucci M; Lazzeri G; Pizzanelli C; Lenzi P; Alessandrl MG; Murri L; Fornai F
Eur J Neurosci; 2003 Jun; 17(12):2593-601. PubMed ID: 12823466
[TBL] [Abstract][Full Text] [Related]
55. Evidence that noradrenergic neurons in the A1 and A2 nuclei are lesioned by low doses of 6-OHDA injected into the locus coeruleus.
Engelbrecht AH; Russell V; Carstens ME; De Villiers AS; Searson A; Jaffer A; Taljaard JJ
J Neurosci Methods; 1994 Apr; 52(1):57-60. PubMed ID: 8090018
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility and resistance of rats to stress-induced decreases in swim-test activity: a selective breeding study.
Scott PA; Cierpial MA; Kilts CD; Weiss JM
Brain Res; 1996 Jul; 725(2):217-30. PubMed ID: 8836528
[TBL] [Abstract][Full Text] [Related]
57. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.
Mague SD; Pliakas AM; Todtenkopf MS; Tomasiewicz HC; Zhang Y; Stevens WC; Jones RM; Portoghese PS; Carlezon WA
J Pharmacol Exp Ther; 2003 Apr; 305(1):323-30. PubMed ID: 12649385
[TBL] [Abstract][Full Text] [Related]
58. The promises and pitfalls of reboxetine.
Page ME
CNS Drug Rev; 2003; 9(4):327-42. PubMed ID: 14647527
[TBL] [Abstract][Full Text] [Related]
59. Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons.
Herman JP; Renda A; Bodie B
Biol Psychiatry; 2003 Jan; 53(2):166-74. PubMed ID: 12547473
[TBL] [Abstract][Full Text] [Related]
60. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test.
Wolak M; Siwek A; Szewczyk B; Poleszak E; Pilc A; Popik P; Nowak G
Pharmacol Rep; 2013; 65(4):991-7. PubMed ID: 24145093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
